Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $598.1 million.

  • Lemaitre Vascular's Liabilities and Shareholders Equity rose 5862.85% to $598.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 5848.29%. This contributed to the annual value of $551.8 million for FY2024, which is 5912.69% up from last year.
  • Per Lemaitre Vascular's latest filing, its Liabilities and Shareholders Equity stood at $598.1 million for Q3 2025, which was up 5862.85% from $577.6 million recorded in Q2 2025.
  • Lemaitre Vascular's Liabilities and Shareholders Equity's 5-year high stood at $598.1 million during Q3 2025, with a 5-year trough of $246.5 million in Q2 2021.
  • Over the past 5 years, Lemaitre Vascular's median Liabilities and Shareholders Equity value was $326.5 million (recorded in 2023), while the average stood at $367.4 million.
  • As far as peak fluctuations go, Lemaitre Vascular's Liabilities and Shareholders Equity plummeted by 360.24% in 2021, and later skyrocketed by 5912.69% in 2024.
  • Over the past 5 years, Lemaitre Vascular's Liabilities and Shareholders Equity (Quarter) stood at $292.8 million in 2021, then increased by 6.04% to $310.5 million in 2022, then increased by 11.69% to $346.8 million in 2023, then skyrocketed by 59.13% to $551.8 million in 2024, then increased by 8.38% to $598.1 million in 2025.
  • Its last three reported values are $598.1 million in Q3 2025, $577.6 million for Q2 2025, and $556.0 million during Q1 2025.